畲族Gc、PGM1、AcP_1、6-ΡGD、ADA和AK1的遗传多态性

对畲族血浆组特异性成分（Ｇｃ）、红细胞磷酸葡萄糖变位酶１（ＰＧＭ１）、酸性磷酸酶（ＡｃＰ１）、６－磷酸葡萄糖酸脱氢酶（６－ＰＧＤ）、腺苷脱氨酶（ＡＤＡ）、腺苷酸激酶（ＡＫ１）的遗传多态性进行了研究。Ｇｃ与ＰＧＭ１是用薄层聚丙烯酰胺凝胶等电聚焦分析的,ＡｃＰ１、６－ＰＧＤ、ＡＤＡ及ＡＫ１是用淀粉凝胶电泳分析的。各基因座的基因频率分别为Ｇｃ＊１Ｆ０．４７２２、Ｇｃ＊１Ｓ０．２４２１、Ｇｃ＊２０．２７３８;ＰＧＭ１＊１Ａ０．５３５７、ＰＧＭ１＊１Ｂ０．１６２７、ＰＧＭ１＊２Ａ０．１５８７、ＰＧＭ１＊２Ｂ０．１４２９;ＡｃＰ＊１Ａ０．１８２５、ＡｃＰ１＊Ｂ０．８１７５;６－ＰＧＤ＊Ａ０．９６８３、６－ＰＧＤ＊Ｂ０．０２７８;ＡＤＡ＊１０．９８８１、ＡＤＡ＊２０．０１１９;ＡＫ１＊１１．００００。畲族Ｇｃ、ＰＧＭ１、ＡｃＰ１、６－ＰＧＤ和ＡＤＡ基因为多态,而ＡＫ１基因为单态。发现１例带有６－ＰＧＤ＊Ｒ和３例带有Ｇｃ＊１Ａ２变异等位基因的个体,其中Ｇｃ＊１Ａ２基因频率为０．０１１９,达到多态水平。     

重组人GM—CSF基因在昆虫细胞中的表达

利用苜蓿夜蛾核型多角体病毒（ＡｃＮＰＶ）带β－Ｇａｌａｃｔｏｓｉｄａｓｅ基因标记的非融合蛋白基因转移载体ｐＢｌｕｅＢａｃ将人粒细胞巨噬细胞集落刺激因子（ｈＧＭ－ＣＳＦ）基因成功地插入病毒ＡｃＮＰＶ的基因组中．ｈＧＭ－ＣＳＦ基因在感染重组病毒的草地夜蛾（Ｓｐｏｄｏｐｔｅｒａｆｒｕｇｉｐｅｒｄａ）培养细胞Ｓｆ９中得到表达,感染后的Ｓｆ９细胞培养液能刺激人骨髓细胞在体外形成典型的集落,表达水平可达２．７×１０５５ＣＦＵ／ｍｌ。以ｈＧＭ－ＣＳＦ单抗所作的ＷｅｓｔｅｒｎＢｌｏｔｔｉｎｇ表明,表达的ｈＧＭ－ＣＳＦ对是３种糖基化程度不同的产物,分子量分别约为１５ｋｄ,１８ｋｄ和２０ｋｄ。     

王不留行环肽研究

从中药王不留行（Ｖａｃａｒｉａｓｅｇｅｔａｌｉｓ）种子中分离并鉴定了４个环肽化合物,分别命名为王不留行环肽Ａ,Ｂ,Ｃ,Ｄ（ｖａｃｃａｒｉｎｓＡ,Ｂ,Ｃ,Ｄ）,其中王不留行环肽Ａ为新环肽化合物。其结构通过光谱和化学方法分别确定为：ｖａｃｃａｒｉｎＡ——ｃｙｃｌｏ－（Ｔｒｐ－Ａｌａ１－Ｇｌｙ－Ｖａｌ－Ａｌａ２）,ｖａｃｃａｒｉｎＢ———ｃｙｃｌｏ－（Ｐｒｏ－Ｇｌｙ－Ｌｅｕ－Ｓｅｒ－Ｐｈｅ１－Ａｌａ－Ｐｈｅ２）,ｖａｃｃａｒｉｎＣ———ｃｙｃｌｏ－（Ｐｒｏ１－Ｇｌｙ－Ｔｙｒ－Ｖａｌ－Ｐｒｏ２－Ｌｅｕ－Ｔｒｐ）,ｖａｃａｒｉｎＤ———ｃｙｃｌｏ－（Ｐｒｏ－Ｖａｌ１－Ｔｒｐ－Ａｌａ－Ｇｌｙ－Ｖａｌ２）．     

重组人MCAF／GM－CSF融合蛋白表达及其生物学活性研究

利用ＰＣＲ技术和ＤＮＡ体外重组方法,把作为导向效应细胞到靶部位的单核细胞趋化激活因子（ＭＣＡＦ）和粒细胞巨噬细胞集落刺激因子（ＧＭ－ＣＳＦ）进行基因融合,置于ｐＢＶ２２０载体的λＰＲＰＬ串联启动子下游,构建了ＳＤ序列与ＡＴＧ之间含有不同核苷酸组成的重组质粒ｐＭＧ０１、ｐＭＧ０２和ｐＭＧ０３。ｐＭＧ０１、ｐＭＧ０２和ｐＭＧ０３的翻译起始区都不存在稳定的二级结构,但ＤＨ５α（ｐＭＧ０２、ＤＨ５α（ｐＭＧ０３）的表达水平远远高于ＤＨ５α（ｐＭＧ０１）,ＤＨ５α（ＰＭＧ０１）几乎没有表达。表达产物经Ｗｅｓｔｅｒｎｂｌｏｔ检测表明,它能分别与ＭＣＡＦ和ＧＭ－ＣＳＦ抗体发生特异反应。生物学活性测定表明,表达产物具有明显的单核细胞趋化活性和维持ｈＧＭ－ＣＳＦ依赖的ＴＦ１细胞生长的特性,说明ＭＣＡＦ和ＧＭ－ＣＳＦ的生物学功能是相容的．     

畲族Ge,PGM1,AcP1,6—PGD,ADA和AK1的遗传多态性

对畲族血浆组特异性成分、红细胞磷酸葡萄糖变位酶１（ＰＧＭ１）、酶性磷酸酶（ＡｃＰ１）、６－磷酸葡萄糖酸氢酶（６－ＰＧＤ）、腺苷脱氨酶（ＡＤＡ０、腺苷酸激酶（ＡＫ１）的遗传多态性进行了研究。Ｇｃ与ＰＧＭ１是用薄层聚丙烯酰胺凝胶等电聚集分析的,ＡｃＰ１、６－ＰＧＤ、ＡＤＡ及ＡＤ１是用淀粉凝胶电泳分析的。各基因座的基因频率分别为Ｇｃ１Ｆ０．４７２２、Ｇｅ１Ｓ０．２４２１、Ｇｃ２０．２７３８;ＰＧＭ１１Ａ     

用逆转录病毒载体表达人粒细胞－巨噬细胞集落刺激因子

应用基因工程的方法,将含有巨细胞病毒（ＣＭＶ）启动子的基因片段和人粒细胞－巨噬细胞集落刺激因子（ｈＧＭ－ＣＳＦ）的ｃＤＮＡ,克隆进逆转录病毒载体Ｎ２Ａ,得到重组质粒Ｎ２Ａ／ＣＭＶ／ｈＧＭ－ＣＳＦ．经脂质体包装并转染包装细胞,通过Ｇ４１８药物筛选,得到抗性克隆。经ＰＣＲ和Ｓｏｕｔｈｅｍｂｌｏｔ检测证实,ＧＭ－ＣＳＦ基因已整合到该克隆细胞的染色体上,获得的逆转录病毒滴度达１０￣４ＣＦＵ／ｍｌ,克隆细胞培养上清用ＴＦ－１细胞可检测到ＧＭ－ＣＳＦ活性。     

常春藤阶段转变研究概况

常春藤阶段转变研究概况包劲松１李载龙１夏英武２（浙江农业大学,１．园艺系,２．核农所,杭州,３１００２９）ＡＳＵＲＶＥＹＦＯＲＰＨＡＥＳＣＨＡＮＧＥＩＮＩＶＹＢａｏＪｉｎｇ－ｓｏｎｇ１ＬｉＺａｉ－ｌｏｎｇ１ＸｉａＹｉｎｇ－ｗｕ２（１．Ｄｅｐａｒｔｍ...     

优化mRNA翻译起始区提高人粒－巨噬细胞集落刺激因子在E．coli中的表达

人粒－巨噬细胞集落刺激因子（ｈＧＭ－ＣＳＦ）是一种重要的造血生长因子．利用基因重组技术构建两个ｈＧＭ－ＣＳＦ的Ｅ．ｃｏｌｉ表达菌株,一个为在不改变氨基酸顺序的前提下,对ｍＲＮＡ翻译起始区核苷酸顺序进行优化突变（ｈＧＭ－ＣＳＦ（Ｍ））,另一个为未突变的对照（ｈＧＭ－ＣＳＦ（Ｎ））．经酶切电泳、ＤＮＡ测序、ＳＤＳ－ＰＡＧＥ和Ｗｅｓｔｅｒｎｂｌｏｔ等分析鉴定,证明两者均能表达特异性的１４．６ｋＤｈＧＭ－ＣＳＦ,但ｈＧＭ－ＣＳＦ（Ｍ）的表达水平较ｈＧＭ－ＣＳＦ（Ｎ）提高了１．２６倍,占菌体总蛋白的１６．９％．ｍＲＮＡ翻译起始区二级结构预测分析表明,优化突变后生成自由能ΔＧ从原来的－１０．２提高至－９．４Ｋｃａｌ,ＡＵＧ从部分配对状态变为非配对状态．     

UV—B辐射对小麦叶片H2O2代谢的影响

研究了温室种植的小麦在０（ＣＫ）、８．８２ｋＪ／ｍ＾２（Ｔ１）和１２．６ｋＪ／ｍ＾２（Ｔ２）三种剂量的紫外线Ｂ（ＵＶ－Ｂ）辐射下Ｈ２Ｏ２含量的变化及其机理。ＵＶ－Ｂ辐射下Ｈ２Ｏ２、还原型抗坏血酸（ＡｓＡ）和还原型谷胱甘肽（ＧＳＨ）含量增加,抗坏血酸过氧化物酶（ＡＰｘ）和谷胱甘肽不原酶（ＧＲ）活性升高,脂肪酸不饱和度指数（ＩＵＦＡ）降低。ＳＤＳ－ＰＡＧＥ谱图没有质上的差异,但凝胶着色深浅有变化。分析     

乙型肝炎病毒表面抗原aa126 Ile→Ser变异株HBsAg的暂时表达和抗原性鉴定

曾在一个儿童患者体内,发现一个新的乙型肝炎病毒（ＨＢＶ）变异株,其ＨＢｓＡｇ主蛋白ａａ１２６发生Ｉｌｅ（ＡＴＴ）到Ｓｅｒ（ＡＧＴ）的取代。已知ａｄｒ／ａｙｒ亚型ＨＢｓＡｇ１２６位为Ｉｌｅ,而ａｄｗ／ａｙｗ亚型ＨＢｓＡｇ１２６位为Ｔｈｒ,表明ＨＢｓＡｇ１２６Ｓｅｒ是一个新的变异株。用计算机做结构分析的结果表明,突变体ＨＢｓＡｇ１２６Ｓｅｒ主蛋白ａａ１２０－ａａ１３０区段的二级结构与野生型ａｄｒＨＢＶＨＢｓＡｇ１２６Ｉｌｅ相比发生明显的改变。这种构象的变化可能会影响ａ抗原决定簇（ａ１２４－ａａ１４７）的抗原性。为了证实这一点,构建了突变Ｓ基因表达质粒,在ＳＶ４０早期启动子的控制下进行抗原表达。利用ＨＢｓＡｇ９肽（Ｔｈｒ－Ｉｌｅ１２６－Ｐｒｏ－Ａｌａ－Ｇｌｎ－Ｇｌｙ－Ｔｈｒ－Ｓｅｒ－Ｍｅｔ）抗ｉ单克隆抗体和９肽（Ｔｈｒ－Ｔｈｒ１２６－Ｐｒｏ－Ａｌａ－Ｇｌｎ－Ｇｌｙ－Ｔｈｒ－Ｓｅｒ－Ｍｅｔ）抗ｔ单克隆抗体进行放射免疫测定,结果表明,这种Ｓｅｒ１２６突变蛋白对抗ｉ单克隆抗体的反应性比野生蛋白减弱,对抗ｔ单克隆抗体的反应性则与ＨＢｓＡｇ１２６Ｔｈｒ接近。但用三种抗－ａ单克隆抗体的检测结果揭示,突变蛋白ＨＢｓＡｇ１２６     

产氨短杆菌GMA-2802 1.2L罐肌苷发酵试验

采用诱变得来的产氨短杆菌GMA－2802,在1.2L自控发酵罐上进行了5批发酵肌苷试验,发酵周期54小时,平均产肌苷20.4g/L。结果表明该菌档是一株具有较多优良特性的肌苷产生菌。     

产氨短杆菌GMA-1112利用味精母液发酵生产肌苷

通过亚硝基胍或60 Coγ辐照等选育一株产氨短杆菌GMA 1 1 1 2 (Ade +Gua +VB1 +8 AGr+SGr+6 MPr) ,能以味精母液代替传统肌苷发酵添加酵母粉作为有机营养物 ,进行肌苷发酵 ,平均产肌苷率 2 5.4 0 g/L。具有降低发酵成本、提高产肌苷率等优点。     

鸟嘌呤核苷高产茵的育种策略

选育优良的鸟嘌呤核苷(鸟苷)产生菌是实现发酵法生产鸟苷的前提,在鸟苷发酵的建立和改进中起着非常重要的作用。本分析了鸟苷的生物合成途径及代谢调节机制,根据代谢控制发酵“进、通、节、堵、出”五字原理,提出鸟苷高产菌的育种策略：鸟苷高产菌株在遗传学上应具备Ade^-,red^-、NP^-、8-AG^r(或8-AX^r)、MSO^r,SG^r,AAR^r,Sm^r等遗传标记,并详述了其育种实例。     

Genetic evidence for possible interaction between a ribonucleic acid polymerase subunit and the spo0C gene product of Bacillus subtilis.

Spontaneous rifampin-resistant mutants (9V Rifr) were isolated from a mutant strain of Bacillus subtilis, 9V, which has a spo0C mutation. Whereas 90% of the 9V Rifr double mutants maintained the Spo0C phenotype (Spo- Abs +/-), the remaining 10% had the Spo0A phenotype (Spo- Abs-). The latter mutants, termed 9V Rifr Spo- Abs-, were revealed to have other Spo0A characters, such as reduced transformability, higher sensitivity to phage phi 2, and reduced frequency of lysogenization by phage phi 105. The rif mutation of these 9V Rifr Spo- Abs- strains was mapped near the cysA locus. The phenotype of the Rifr transformants of strain 9V by deoxyribonucleic acid derived from these 9V Rifr Spo- Abs- strains was Spo0A, and that of the Rifr transformants of strain 168 was Spo+ Abs+. The ribonucleic acid polymerase of the 9V Rifr Spo- Abs- strains was shown to be resistant to rifampin.     

Survival of rifampin-resistant mutants of Pseudomonas fluorescens and Pseudomonas putida in soil systems.

The fate of spontaneous chromosomal rifampin-resistant (Rifr) mutants of Pseudomonas putida and Pseudomonas fluorescens in sterile and live organic soil from which they were isolated was studied. In sterile native-soil assays, a Rifr mutant of P. putida showed no decrease in competitive fitness when compared with the wild-type parent. However, mutants of P. fluorescens were of two general categories. Group 1 showed no difference from the wild type in terms of growth rate, competitive fitness, and membrane protein composition. Group 2 showed a slower growth rate in both minimal and enriched media and an altered membrane protein profile. These mutants also demonstrated decreased competitive fitness compared with the wild-type strain. In live soil, the Rifr P. putida strain persisted throughout the 38-day test period with a decay rate of 0.7 log10 CFU/g of soil per 10 days. A group 1 Rifr P. fluorescens mutant maintained its inoculated titer for 7 to 10 days and then decayed at a rate of 0.2 to 0.4 log10 CFU/g of soil per 10 days. A group 2 Rifr P. fluorescens mutant remained at its titer for 1 to 5 days before decaying at a two- to threefold-faster rate. These findings indicate that rifampin resistance may not be an innocuous mutation in some pseudomonads and that marked strains should be compared with wild-type parents before being used as monitors of parental strain survival. Colonization of sterile soil with either the wild-type or mutant strain precluded normal colonization of the second added strain.(ABSTRACT TRUNCATED AT 250 WORDS)     

Survival of rifampin-resistant mutants of Pseudomonas fluorescens and Pseudomonas putida in soil systems

The fate of spontaneous chromosomal rifampin-resistant (Rifr) mutants of Pseudomonas putida and Pseudomonas fluorescens in sterile and live organic soil from which they were isolated was studied. In sterile native-soil assays, a Rifr mutant of P. putida showed no decrease in competitive fitness when compared with the wild-type parent. However, mutants of P. fluorescens were of two general categories. Group 1 showed no difference from the wild type in terms of growth rate, competitive fitness, and membrane protein composition. Group 2 showed a slower growth rate in both minimal and enriched media and an altered membrane protein profile. These mutants also demonstrated decreased competitive fitness compared with the wild-type strain. In live soil, the Rifr P. putida strain persisted throughout the 38-day test period with a decay rate of 0.7 log10 CFU/g of soil per 10 days. A group 1 Rifr P. fluorescens mutant maintained its inoculated titer for 7 to 10 days and then decayed at a rate of 0.2 to 0.4 log10 CFU/g of soil per 10 days. A group 2 Rifr P. fluorescens mutant remained at its titer for 1 to 5 days before decaying at a two- to threefold-faster rate. These findings indicate that rifampin resistance may not be an innocuous mutation in some pseudomonads and that marked strains should be compared with wild-type parents before being used as monitors of parental strain survival. Colonization of sterile soil with either the wild-type or mutant strain precluded normal colonization of the second added strain.(ABSTRACT TRUNCATED AT 250 WORDS)     

Ribonucleic acid polymerase mutation affecting glutamate synthase activity in and sporulation of Bacillus subtilis.

Spore formation of 15 rifampin-resistant (Rifr) mutants of Bacillus subtilis strain 168 was examined. As a pleiotropic effect of a Rifr mutation, glutamate synthase activity was lost in these mutants. Twelve of the 15 mutants examined formed as many spores as the parent, but the remaining 3 formed significantly fewer (1%) spores. One of the latter mutants characterized further (RF301) was blocked in its sporulation process at stage 0. Thus, it was concluded that a certain modification of ribonucleic acid polymerase may affect specifically the gene expression of glutamate synthase and also the sporulation process at the initial stage.     

Formation of virulent antigen-modified mutants (Fra-, Fra-Tox-) of plague bacteria resistant to rifampicin and quinolones]

Experiments were performed with two strains of plague bacteria--231 (isolated from marmot) and 358 (isolated from human) and their isogenic variants with Fra- and Fra-Tox- phenotype. Mutants resistant to rifampicin (Rifr) and nalidixic acid (Nalr) appeared independently of pathogen phenotype and genotype with frequency n.10(-8)-n.10(-9), subsequently. Rifr mutation influenced on virulence manifestation at albino mice and antigendeficient variants with Fra- and Fra-Tox- phenotype. In every group of strains highly virulent subcultures were registered. Resistance to nalidixic acid mainly was not associated with virulence loss. Nalr mutants of parent and antigenmodified mutants were cross resistant to fluoroqinolones (ciprofloxacin, ofloxacin, pefloxacin, lomefloxacin). LD50 for untreated albino mice did not differ from LD50, for mice treated with rifampicin (when mice were infected with strain resistant to rifampicin) or with nalidixic acid and fluoroquinolones (when animals were infected with Nalr mutants). Antigenmodified strains of plague bacteria and their Rifr, Nalr mutants were able to overcome specific immune reaction. The drugs should be used in synergic combinations (with aminoglycosides or cephalosporines of III generation) to prevent appearance of virulent strains resistant to rifampicin and fluroquinolones.     

Escherichia coli K-12 mutants with increased resistance to ionizing radiation. V. The effect of mutations on spontaneous and radiation mutagenesis

The frequencies of spontaneous mutations (reversions his-4----His+ and forward mutations to rifampicin-, nalidixic acid- or valine-resistance) in radiation-resistant mutants Gamr444 and Gamr445 are much lower than in the wild-type strain AB1157. His+ revertants and rifampicin-resistant mutants Rifr are induced by low doses of gamma-rays more efficiently than in the wild-type. Low doses of UV light only enhanced mutagenic activity in Gamr strains for induction of His+ reversions but not for Rifr mutations. For the wild-type strain the frequencies of His+ and Rifr mutations increase proportionally to the square of dose both of UV light and gamma-rays. For the most radioresistant Gamr444 mutant the frequencies of UV- and gamma-rays-induced Rifr mutations and of gamma-rays-induced reversions increase linearly with the dose. Possible reasons for these anomalies of radiation-induced mutagenesis in Gamr mutants are discussed.